CSL – Not yet !

CSL.AX registers a weekly oversold reading for only the 3rd notable time since its publicly listed, 30 years ago, back in 1994.

Mean reversion is one thing, then oversold on a weekly basis is another measure but it looks like it has lower to go before the stock price resembles some type of exhaustion.

The stock price of this Australian multi-specialty biotechnology company will likely mimic the various ‘metrics’ (not stock price) which it experienced in August 2011 before I think its risk/reward skew is ravishing.

October 12, 2023

by Rob Zdravevski

rob@karriasset.com.au